A new case report published in Clinical Neurophysiology describes the first known administration of psilocybin—a psychedelic ...

A new study finds that psilocybin — a psychedelic compound in certain mushrooms — can improve mood, cognitive function, and ...

In the midst of a statewide and national debate about the clinical use of psilocybin, Sean Schriver thinks of two people in ...

After a rejected psilocybin measure, some still push for its mental health benefits. Hear one couple’s story on the Love ...

Harm caused by repeated concussions, especially in the context of sports, has gained attention in both research and the media ...

Colorado lawmakers are considering legislation that would charge the state health agency to collect data and information on ...

In a world first, Tryptamine Therapeutics is using intravenously-delivered psilocybin in a binge easting disorder clinical ...

Discover how psilocybin therapy could transform Parkinson’s care - read more about this promising pilot trial and future ...

The prevalence of lifetime and past-year use of psilocybin increased from 2019 to 2023 among all age groups in the United States.

New research reveals that psychedelics like psilocybin do more than alter brain activity — they reshape how the brain and immune system communicate.

Fintel reports that on May 7, 2025, Chardan Capital initiated coverage of Bright Minds Biosciences (NasdaqCM:DRUG) with a Buy ...